This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients

This study has been completed.
Information provided by (Responsible Party):
Zimmer Biomet Identifier:
First received: January 14, 2010
Last updated: March 17, 2017
Last verified: December 2012
This is a feasibility study to determine if anti-inflammatory cytokines can be concentrated from patients with osteoarthritis.


Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: A Feasibility Study to Determine the Up-regulation of Anti-inflammatory Cytokines in Whole Blood From Patients With Osteoarthritis

Resource links provided by NLM:

Further study details as provided by Zimmer Biomet:

Primary Outcome Measures:
  • Measure anti-inflammatory cytokines [ Time Frame: immediately after processing ]

Enrollment: 105
Study Start Date: May 2010
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
osteoarthritis patients


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with evidence of osteoarthritis.

Inclusion Criteria:

  • radiographic evidence of osteoarthritis
  • signed informed consent

Exclusion Criteria:

  • Pregnancy
  • < 18 years of age
  • blood clotting disorder or active hematologic cancer
  • undergoing chemotherapy
  • history of rheumatoid arthritis
  • septic joint or fracture
  • active infection or history of chronic infection
  • use of cytokine blocking drugs with the last 6 months
  • intra-articular steroid or hyaluronic acid (HA) injection within last 6 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01050894

United States, Indiana
Indianapolis, Indiana, United States, 4646237
United States, Kentucky
Orthopaedic Surgery, Kentucky Clinic
Lexington, Kentucky, United States, 40506
United States, Ohio
Ohio State University Sports Medicine Center
Columbus, Ohio, United States, 43221
Sponsors and Collaborators
Zimmer Biomet
  More Information

Responsible Party: Zimmer Biomet Identifier: NCT01050894     History of Changes
Other Study ID Numbers: APS-001
Study First Received: January 14, 2010
Last Updated: March 17, 2017

Keywords provided by Zimmer Biomet:

Additional relevant MeSH terms:
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Anti-Inflammatory Agents processed this record on September 21, 2017